X4 Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,973 | $28,807 | $1,434 | $560 |
Gross Profit | 1,647 | 24,091 | 1,132 | 333 |
EBITDA | -26,232 | 2,993 | -36,986 | -34,000 |
EBIT | 2,517 | -37,259 | -34,267 | |
Net Income | -25,741 | 282 | -39,821 | -36,696 |
Net Change In Cash | 1,973 | 28,807 | 1,434 | 560 |
Free Cash Flow | -29,901 | -15,368 | -33,036 | -34,124 |
Cash | 39,220 | 40,257 | 55,699 | 97,412 |
Basic Shares | 7,412 | 6,869 | 6,701 | 6,695 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,557 | $0 | $0 | $0 |
Gross Profit | 1,760 | -1,996 | -1,994 | -1,892 |
EBITDA | -27,576 | -107,103 | -87,569 | -84,538 |
EBIT | -28,372 | -107,522 | -89,563 | -85,037 |
Net Income | -37,450 | -101,167 | -93,867 | -88,696 |
Net Change In Cash | 2,557 | 0 | 0 | 0 |
Cost of Revenue | 40,025 | |||
Free Cash Flow | -131,227 | -96,572 | -77,205 | -71,520 |
Cash | 55,699 | 99,216 | 121,718 | 81,787 |
Basic Shares | 6,701 | 5,927 | 2,117 | 858 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$3.47 |
2025-03-31 | $0.04 |
2024-12-31 | -$0.20 |
2024-09-30 | -$0.18 |
